No association between severe constipation with related drug treatment in pregnant women and congenital abnormalities in their offspring

A population-based case-control study

Research output: Contribution to journalArticle

9 Citations (Scopus)

Abstract

Constipation is a common pathological condition in pregnant women; nevertheless, its possible association with structural birth defects (i.e. congenital abnormalities [CA]) in their offspring has not been studied in controlled epidemiological studies. We evaluated the possible association between severe constipation with laxative treatment in pregnant women and congenital abnormalities in their offspring. The dataset of the population-based Hungarian Case-Control Surveillance System of Congenital Abnormalities (HCCSCA) 1980-1996 contained 22 843 cases with CA and 38 151 matched controls without CA. Only pregnant women with prospectively and medically recorded constipation were included in the study and 13 CA groups were compared in cases and all their matched controls. A total of 78 (0.34%) cases had mothers with severe constipation and treatment during pregnancy compared to 144 (0.38%) controls (adjusted OR with 95% CI = 1.0, 0.7-1.3). Specified groups of CA were also assessed versus controls, but a higher occurrence of pregnant women with severe constipation and related treatment was not found in any CA group. Among laxative drugs, senna has no teratogenic potential; thus, if severe constipation requires laxative drug treatment in pregnant women, senna is not contraindicated. A higher rate of CA was not found in the offspring of pregnant women with severe constipation and related senna treatment.

Original languageEnglish
Pages (from-to)15-20
Number of pages6
JournalCongenital Anomalies
Volume50
Issue number1
DOIs
Publication statusPublished - Mar 2010

Fingerprint

Constipation
Case-Control Studies
Pregnant Women
Pharmaceutical Preparations
Population
Laxatives
Therapeutics
Epidemiologic Studies
Mothers
Pregnancy

Keywords

  • Case-control study
  • Congenital abnormality
  • Constipation during pregnancy
  • Maternal effect
  • Related treatment

ASJC Scopus subject areas

  • Developmental Biology
  • Pediatrics, Perinatology, and Child Health
  • Embryology

Cite this

@article{ea34e3cfa793430aa6d7be67b7cd42e6,
title = "No association between severe constipation with related drug treatment in pregnant women and congenital abnormalities in their offspring: A population-based case-control study",
abstract = "Constipation is a common pathological condition in pregnant women; nevertheless, its possible association with structural birth defects (i.e. congenital abnormalities [CA]) in their offspring has not been studied in controlled epidemiological studies. We evaluated the possible association between severe constipation with laxative treatment in pregnant women and congenital abnormalities in their offspring. The dataset of the population-based Hungarian Case-Control Surveillance System of Congenital Abnormalities (HCCSCA) 1980-1996 contained 22 843 cases with CA and 38 151 matched controls without CA. Only pregnant women with prospectively and medically recorded constipation were included in the study and 13 CA groups were compared in cases and all their matched controls. A total of 78 (0.34{\%}) cases had mothers with severe constipation and treatment during pregnancy compared to 144 (0.38{\%}) controls (adjusted OR with 95{\%} CI = 1.0, 0.7-1.3). Specified groups of CA were also assessed versus controls, but a higher occurrence of pregnant women with severe constipation and related treatment was not found in any CA group. Among laxative drugs, senna has no teratogenic potential; thus, if severe constipation requires laxative drug treatment in pregnant women, senna is not contraindicated. A higher rate of CA was not found in the offspring of pregnant women with severe constipation and related senna treatment.",
keywords = "Case-control study, Congenital abnormality, Constipation during pregnancy, Maternal effect, Related treatment",
author = "N. {\'A}cs and F. B{\'a}nhidy and E. Puh{\'o} and E. Czeizel",
year = "2010",
month = "3",
doi = "10.1111/j.1741-4520.2009.00252.x",
language = "English",
volume = "50",
pages = "15--20",
journal = "Congenital Anomalies",
issn = "0914-3505",
publisher = "Wiley-Blackwell",
number = "1",

}

TY - JOUR

T1 - No association between severe constipation with related drug treatment in pregnant women and congenital abnormalities in their offspring

T2 - A population-based case-control study

AU - Ács, N.

AU - Bánhidy, F.

AU - Puhó, E.

AU - Czeizel, E.

PY - 2010/3

Y1 - 2010/3

N2 - Constipation is a common pathological condition in pregnant women; nevertheless, its possible association with structural birth defects (i.e. congenital abnormalities [CA]) in their offspring has not been studied in controlled epidemiological studies. We evaluated the possible association between severe constipation with laxative treatment in pregnant women and congenital abnormalities in their offspring. The dataset of the population-based Hungarian Case-Control Surveillance System of Congenital Abnormalities (HCCSCA) 1980-1996 contained 22 843 cases with CA and 38 151 matched controls without CA. Only pregnant women with prospectively and medically recorded constipation were included in the study and 13 CA groups were compared in cases and all their matched controls. A total of 78 (0.34%) cases had mothers with severe constipation and treatment during pregnancy compared to 144 (0.38%) controls (adjusted OR with 95% CI = 1.0, 0.7-1.3). Specified groups of CA were also assessed versus controls, but a higher occurrence of pregnant women with severe constipation and related treatment was not found in any CA group. Among laxative drugs, senna has no teratogenic potential; thus, if severe constipation requires laxative drug treatment in pregnant women, senna is not contraindicated. A higher rate of CA was not found in the offspring of pregnant women with severe constipation and related senna treatment.

AB - Constipation is a common pathological condition in pregnant women; nevertheless, its possible association with structural birth defects (i.e. congenital abnormalities [CA]) in their offspring has not been studied in controlled epidemiological studies. We evaluated the possible association between severe constipation with laxative treatment in pregnant women and congenital abnormalities in their offspring. The dataset of the population-based Hungarian Case-Control Surveillance System of Congenital Abnormalities (HCCSCA) 1980-1996 contained 22 843 cases with CA and 38 151 matched controls without CA. Only pregnant women with prospectively and medically recorded constipation were included in the study and 13 CA groups were compared in cases and all their matched controls. A total of 78 (0.34%) cases had mothers with severe constipation and treatment during pregnancy compared to 144 (0.38%) controls (adjusted OR with 95% CI = 1.0, 0.7-1.3). Specified groups of CA were also assessed versus controls, but a higher occurrence of pregnant women with severe constipation and related treatment was not found in any CA group. Among laxative drugs, senna has no teratogenic potential; thus, if severe constipation requires laxative drug treatment in pregnant women, senna is not contraindicated. A higher rate of CA was not found in the offspring of pregnant women with severe constipation and related senna treatment.

KW - Case-control study

KW - Congenital abnormality

KW - Constipation during pregnancy

KW - Maternal effect

KW - Related treatment

UR - http://www.scopus.com/inward/record.url?scp=77649196889&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77649196889&partnerID=8YFLogxK

U2 - 10.1111/j.1741-4520.2009.00252.x

DO - 10.1111/j.1741-4520.2009.00252.x

M3 - Article

VL - 50

SP - 15

EP - 20

JO - Congenital Anomalies

JF - Congenital Anomalies

SN - 0914-3505

IS - 1

ER -